Versus other vaginal progesterones—

A Decade of Uncompromised Luteal Support, Consistently
Patient Preferred

Click on the Lead Author’s name for more information about each study.

Lead Author	Comparable Pregnancy Outcomes	Patient Preferred
Doody K1 Fertil Steril, 2007		Not assessed
Simunic V2 Fertil Steril, 2007
Geber S3 Reprod BioMed Online, 2007		Not assessed
Ludwig M4 Eur J Obstet Gynecol Reprod Biol, 2002
Alper MM5 ESHRE,* 2000		Not assessed
Williams SC6 Fertil Steril, 2000		Not assessed

References: 1. Doody K, Shamma N, Paulson R, Bayer S, Blake E, Yankov V. Endometrin® for luteal phase support in a randomized, controlled, open-label, prospective IVF clinical trial using a combination of Menopur® and Bravelle®. Fertil Steril. 2007;87(Suppl 2):S24. Abstract P-34. 2. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril. 2007;87:83–87. 3. Geber S, Moreira AC, de Paula SO, Sampaio M. Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. Reprod BioMed Online. 2007;14:155–158. Available at: rbmonline.com/Article/2551. 4. Ludwig M, Schwartz P, Babahan B, et al. Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol. 2002;103:48–52. 5. Alper MM, Penzias AS. Crinone® offers excellent implantation rates in patients undergoing IVF. Paper presented at the 16th Annual Meeting of the European Society for Human Reproduction & Embryology; June 2000; Bologna, Italy. Abstract P-059. 6. Williams SC, Donahue J, Muasher SJ. Vaginal progesterone thereapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates. Fertil Steril. 2000;74(suppl 1):S209. Abstract P-363.